Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation

Genes and Development

Volumn 10, Issue 19, 1996, Pages 2478-2490

  Eckner, Richard ^a,b   Yao, Tso Pang ^a   Oldread, Elizabeth ^a   Livingston, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

B cell differentiation; myogenesis; p300 CBP

Indexed keywords

DIFFERENTIATION ANTIGEN; HELIX LOOP HELIX PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL SPECIFICITY; DNA PROTEIN COMPLEX; GENE TARGETING; GROWTH REGULATION; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0029825698     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.19.2478     Document Type: Article

References (65)

1. Alema, S. and F. Tato. 1994. Oncogenes and muscle differentiation: Multiple mechanisms of interference. Cancer Biol. 5: 147-156.
2. Arany, Z., W.R. Sellers, D.M. Livingston, and R. Eckner. 1994. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77: 799-800.
3. Arany, Z., D. Newsome, E. Oldread, D.M. Livingston, and R. Eckner. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374: 81-84.
4. Arias, J., A.S. Alberts, P. Brindle, F.X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226-229.
5. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, J.G. Seidman, and K. Struhl. 1989. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, NY.
6. Bain, G., E.G. Robanus Maandag, D.J. Izon, D. Amsen, A.M. Kruisbeek, B.C. Weintraub, I. Krop, M.S. Schlissel, A.J. Feeney, M. van Roon, M. van der Falk, H.P.J. te Riele, A. Berns, and G. Murre. 1994. E2A proteins are required for proper B cell development and initiation of Immunoglobulin gene rearrangments. Cell 79: 885-892.
7. Bayley, S.T. and J.S. Mymryk. 1994. Adenovirus E1A proteins and transformation. Int. J. Oncol. 5: 425-444.
8. Borrelli, E., R. Hen, and P. Chambon. 1984. Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription. Nature 312: 608-612.
9. Borrelli, E., R. Hen, C. Wasylyk, and P. Chambon. 1986. The immunoglobulin heavy chain enhancer is stimulated by the adenovirus type 2 E1A products in mouse fibroblasts. Proc. Natl. Acad. Sci. 83: 2846-2849.
10. Boulukos, K.E. and E.B. Ziff. 1993. Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor reponsiveness of PC12 cells by a conserved region 1-dependent mechanism. Oncogene 8: 237-248.
11. Bour, B.A., M.A. O'Brien, W.L. Lockwood, E.S. Goldstein, R. Bodmer, P.H. Taghert, S. Abmayr, and H.T. Nguyen. 1995. Drosophila MEF2, a trascription factor that is essential for myogenesis. Genes & Dev. 9: 730-741.
12. Braun, T. and H.-H. Arnold. 1996. myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J. 15: 310-318.
13. Braun, T., E. Bober, and H.H. Arnold. 1992a. Inhibition of muscle differentiation by the adenovirus E1a protein: Repression of the transcriptional activating function of the HLH protein Myf-5. Genes & Dev. 6: 888-902.
14. Braun, T., M.A. Rudnicki, H.-H. Arnold, and R. Jaenisch. 1992b. Targeted Inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71: 369-382.
15. Buskin, J.N. and S.D. Hauschka. 1989. Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol. Cell. Biol. 9: 2627-2640.
16. Chrivia, J.C., R.P.S. Kwok, N. Lamb, M. Hagiwara, M.R. Montminy, and R.H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365: 855-859.
17. Eckner, R., M.E. Ewen, D. Newsome, M. Gerdes, J.A. DeCaprio, J.B. Lawrence, and D.M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes & Dev. 8: 869-884.
18. Eckner, R., J.W. Ludlow, N. Lill, E. Oldread, Z. Arany, N. Modjtahedi, J.A DeCaprio, D.M. Livingston, and J.A. Morgan. 1996. Association of p300 and CBP with SV40 large T antigen. Mol Cell Biol. 16: 3454-3464.
19. Ernst, P. and S.T. Smale. 1995. Combinatorial regulation of transcription II: The immunoglobulin μ heavy chain gene. Immunity 2: 427-438.
20. Goldhamer, D., B. Brunk, A. Faerman, A. King, M. Shani, and C.P. Emerson. 1995. Embryonic activation of myoD is regulated by a highly conserved distal control element. Development 121: 637-649.
21. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
22. Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searcy, R. Kurokawa, and M. Brown. 1996. p300 is a component of an estrogen receptor co-activator complex. Proc. Natl. Acad. Sci. 93: (in press).
23. Harlow, E. and D. Lane. 1988. Antibodies: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
24. Harlow, E., L.V. Crawford, D.C. Pim, and N.M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39: 861-869.
25. Hasty, P., A. Bradley, J.H. Horris, D.G. Edmondson, J.M. Venuti, E.N. Olson, and W.H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506.
26. Hollenberg, S.M., P.F. Cheng, and H. Weintraub. 1993. Use of a conditional myoD transcription factor in studies of myoD trans-activation and muscle determination. Proc. Natl. Acad. Sci. 90: 8028-8032.
27. Jan, Y.N. and L.Y. Jan. 1993. HLH proteins, fly neurogenesis, and vertebrate myogenesis. Cell 75: 827-830.
28. Jaynes, J.B., J.E. Johnson, J.N. Buskin, C.L. Gartside, and S.D. Hauschka. 1988. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol Cell. Biol. 8: 62-70.
29. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S-C Lin, R.A. Heyman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
30. Kaushal, S., J.W. Schneider, B. Nadal-Ginard, and V. Mahdavi. 1994. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with myoD. Science 266: 1236-1240.
31. Kiledjian, M., L.-K. Su, and T. Kadesch. 1988. Identification and characterization of two functional domains within the murine heavy chain enhancer. Mol. Cell. Biol. 8: 145-152.
32. Kitabayashi, I., R. Eckner, Z. Arany, R. Chiu, G. Gachelin, D.M. Livingston, and K. Yokoyama. 1995. Phosphorylation of the adenovirus E1A-associated 300-kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells. EMBO J. 14: 3496-3509.
33. Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol. Cell. Biol. 15: 5205-5213.
34. Kopan, R., J.S. Nye, and H. Weintraub. 1994. The intracellular domain of mouse Notch: A constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 120: 2385-2396.
35. Kuisk, I..R., H. Li, D. Tran, and Y. Capetanaki. 1996. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev. Biol. 174: 1-13.
36. Lassar, A.B., J.N. Buskin, D. Lockshon, R.L. Davis, S. Apone, S.D. Hauschka, and H. Weintraub. 1989. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58: 823-831.
37. Lassar, A.B., R.L. Davis, W.E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66: 305-315.
38. Li, L., R. Heller-Harrison, M. Czech, and E.N. Olson. 1992. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol. Cell. Biol. 12: 4478-4485.
39. Lilly, B., B. Zhao, G. Ranganayakulu, B.M. Paterson, R.A. Schulz, and E.N. Olson. 1995. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267: 688-693.
40. Ma, P.C.M., M.A. Rould, H. Weintraub, and C.O. Pabo. 1994. Crystal structure of MyoD bHLH domain-DNA complex: Perspectives on DNA recognition and implications for transcriptional activation. Cell 77: 451-459.
41. Molkentin, J.D., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136.
42. Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycles. Curr. Opin. Genet. Dev. 3: 63-70.
43. 3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Mol. Biol Cell 3: 1107-1115.
44. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, L. Nonaka, and Y. Nebeshima. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364: 532-535.
45. Olson, E.N., M. Perry, and R.A. Schulz. 1995. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. Biol. 172: 2-14.
46. Olson, E.N., H.-H. Arnold, P.W.J. Rigby, and B.J. Wold. 1996. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85: 1-4.
47. Piette, J., J.-L. Bessereau, M. Huchet, and J.-P. Changeux. 1990. Two adjacent MyoD1-binding sites regulate expression of the acetylcholine receptor α-subunit gene. Nature 345: 353-355.
48. Rudnicki, M.A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of myoD in mice leads to up-regulation of the myogenic HLH gene myf-5 and results in apparently normal muscle development. Cell 71: 383-390.
49. Rudnicki, M.A., P.N.J. Schnegelsberg, R.H. Stead, T. Braun, H.H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351-1359.
50. Ruezinsky, D., H. Beckmann, and T. Kadesch. 1991. Modulation of the IgH enhancer's cell type specificity through a genetic switch. Genes &. Dev. 5: 29-37.
51. Salminen, A., T. Braun, A. Buchberger, S. Jürs, B. Winter, and H.-H. Arnold. 1991. Transcription of the muscle regulatory gene Myf4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins. J. Cell Biol. 115: 905-917.
52. Schlissel, M., A. Voronova, and D. Baltimore. 1991. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes & Dev. 5: 1367-1376.
53. Schreiber, E., P. Matthias, M.M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
54. Shen, C.-P. and T. Kadesch. 1995. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15: 4518-1524.
55. Shivdasani, R.A., E.L. Mayer, and S.H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein lal-1/SCL. Nature 373: 432-434.
56. Stein, R., M. Corrigan, P. Yaciuk, J. Whelan, and E. Moran. 1990. Analysis of E1A-mediated growth regulation functions: Binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J. Virol. 64: 4421-4427.
57. Tapscott, S.J., R.L. Davis, M.J. Thayer, P.-F. Cheng, H. Weintraub, and A.B. Lassar. 1988. MyoD1: A nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242: 405-411.
58. Webster, K.A., G.E.O. Muscat, and L. Kedes. 1988. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature 332: 553-557.
59. Weintraub, H. 1993. The MyoD family and myogenesis: Redundancy, networks, and threshholds. Cell 75: 1241-1244.
60. Weintraub, H., R. Davis, D. Lockshon, and A. Lassar. 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. 87: 5623-5627.
61. Weintraub, H., V.J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S.J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes & Dev. 5: 1377-1386.
62. Wentworth, B.M., M. Donoghue, J.C. Engert, E.B. Berglund, and N. Rosenthal. 1991. Paired myoD-binding sites regulate myosin light chain gene expression. Proc. Natl. Acad. Sci. 88: 1242-1246.
63. Winter, B., T. Braun, and H.H. Arnold. 1993. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors myf-5 and myoD. J. Biol. Chem. 268: 9869-9878.
64. Yao, T.-P., G. Ku, N. Zhou, R. Scully, and D.M. Livingston. 1996. The nuclear hormone receptor co-activator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. 93: (in press).
65. Zhuang, Y., P. Soriano, and H. Weintraub. 1994. The helix-loophelix gene E2A is required for B cell formation. Cell 79: 875-884.